Hostname: page-component-848d4c4894-pftt2 Total loading time: 0 Render date: 2024-06-01T06:41:52.327Z Has data issue: false hasContentIssue false

Incidence of First-Episode Status Epilepticus and Risk Factors in Ontario, Canada

Published online by Cambridge University Press:  05 February 2024

R. Grace Couper
Affiliation:
Neuroepidemiology Research Unit, Department of Clinical Neurological Sciences, Western University, London, ON, Canada
Tresah C. Antaya
Affiliation:
Neuroepidemiology Research Unit, Department of Clinical Neurological Sciences, Western University, London, ON, Canada Department of Epidemiology and Biostatistics, Western University, London, ON, Canada
Piotr Wilk
Affiliation:
Department of Epidemiology and Biostatistics, Western University, London, ON, Canada Department of Paediatrics, Schulich School of Medicine & Dentistry, Western University, London, ON, Canada ICES Western, London, ON, Canada Departments of Epidemiology, Maastricht University, Maastricht, The Netherlands
Teneille Gofton
Affiliation:
Department of Clinical Neurological Sciences, Western University, London, ON, Canada
Derek B. Debicki
Affiliation:
Department of Clinical Neurological Sciences, Western University, London, ON, Canada
Jorge G. Burneo*
Affiliation:
Neuroepidemiology Research Unit, Department of Clinical Neurological Sciences, Western University, London, ON, Canada Department of Epidemiology and Biostatistics, Western University, London, ON, Canada ICES Western, London, ON, Canada Department of Clinical Neurological Sciences, Western University, London, ON, Canada
*
Corresponding author: J. G. Burneo; Email: jburneo2@uwo.ca

Abstract

Background:

Status epilepticus (SE) is a neurological emergency characterized by prolonged seizures. However, the incidence of first-episode SE is unclear, as estimates vary greatly among studies. Additionally, SE risk factors have been insufficiently explored. Therefore, the objectives of this study were to estimate the incidence of first-episode SE in Ontario, Canada, and estimate the associations between potential sociodemographic and health-related risk factors and first-episode SE.

Methods:

We conducted a population-based retrospective cohort study using linked health administrative datasets. We included individuals who completed Canada’s 2006 Census long-form questionnaire, lived in Ontario, were between 18 and 105, and had no history of SE. A Cox proportional hazards regression model was used to estimate the hazard ratios for SE within three years associated with each potential risk factor.

Results:

The final sample included 1,301,700 participants, 140 of whom were hospitalized or had an emergency department visit for first-episode SE during follow-up (3.5 per 100,000 person-years). Older age was the only significant sociodemographic SE risk factor (HR = 1.35, 95% CI = 1.33, 1.37), while health-related risk factors included alcohol or drug abuse (HR = 1.05, 95% CI = 1.02, 1.08), brain tumour or cancer (HR = 1.14, 95% CI = 1.12, 1.15), chronic kidney disease (HR = 1.32, 95% CI = 1.29, 1.36), dementia (HR = 1.42, 95% CI = 1.36, 1.48), diabetes (HR = 1.11, 95% CI = 1.09, 1.12), epilepsy or seizures (HR = 1.05, 95% CI = 1.01, 1.09) and stroke (HR = 1.08, 95% CI = 1.05, 1.11).

Conclusion:

The estimated incidence of SE in a sample of Ontario residents was 3.5 per 100,000 person-years. Older age and several comorbid conditions were associated with higher first-episode SE risk.

Résumé

RÉSUMÉ

Incidence des premiers épisodes d’état de mal épileptique et facteurs de risque en Ontario (Canada)

Contexte :

L’état de mal épileptique (EME) est une urgence neurologique caractérisée par des crises convulsives prolongées. Cependant, l’incidence des premiers épisodes d’EME demeure méconnue dans la mesure où les estimations varient considérablement d’une étude à l’autre. En outre, les facteurs de risque de l’EME n’ont pas été suffisamment explorés. Par conséquent, les objectifs de cette étude étaient d’estimer l’incidence des premiers épisodes d’EME en Ontario (Canada) et d’estimer les associations entre ces mêmes premiers épisodes et des facteurs de risque sociodémographiques et liés à la santé.

Méthodes :

Nous avons ainsi mené une étude de cohorte rétrospective basée sur la population en utilisant des ensembles de données administratives liées à la santé. Nous avons inclus les individus ayant rempli le questionnaire détaillé du recensement canadien de 2006 qui vivaient en Ontario, qui avaient entre 18 et 105 ans et qui n’avaient pas d’antécédents d’EME. À cet égard, un modèle de régression des risques proportionnels de Cox a été utilisé pour estimer, sur une période de trois ans, les rapports de risque de l’EME associés à chaque facteur potentiel de risque.

Résultats :

Notre échantillon final comprenait 1 301 700 participants, dont 140 avaient été hospitalisés ou s’étaient rendus aux urgences en raison d’un premier épisode d’EME au cours d’un suivi (3,5 par 100 000 personnes-années). L’âge avancé d’un individu s’est révélé le seul facteur de risque sociodémographique significatif de l’EME (RRI = 1,35 ; IC 95 % = 1,33-1,37) tandis que les facteurs de risque liés à la santé ont inclus l’abus d’alcool ou de drogues (RRI = 1,05 ; IC 95 % = 1,02-1,08), la présence d’une tumeur cérébrale ou d’un cancer (RRI = 1,14 ; IC 95 % = 1,12-1,15), l’insuffisance rénale chronique (RRI = 1,32 ; IC 95 % = 1,29-1,36), la démence (RRI = 1,42 ; IC 95 % = 1,36-1,48), le diabète (RRI = 1,11 ; IC 95 % = 1,09-1,12), l’épilepsie ou des crises convulsives (RRI = 1,05 ; IC 95 % = 1,01-1,09) ainsi que les AVC (RRI = 1,08 ; IC 95 % = 1,05-1,11).

Conclusion :

L’incidence estimée de l’EME dans un échantillon de résidents de l'Ontario était de 3,5 par 100 000 années-personnes. De plus, l’âge avancé de ces résidents de même que plusieurs comorbidités ont été associés à un risque plus élevé d’être victime d’un premier épisode d’EME.

Type
Original Article
Copyright
© The Author(s), 2024. Published by Cambridge University Press on behalf of Canadian Neurological Sciences Federation

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Trinka, E, Cock, H, Hesdorffer, D, et al. A definition and classification of status epilepticus - report of the ILAE task force on classification of status epilepticus. Epilepsia. 2015;56:1515–23.CrossRefGoogle ScholarPubMed
Betjemann, JP, Josephson, SA, Lowenstein, DH, Burke, JF. Trends in status epilepticus-related hospitalizations and mortality: redefined in US practice over time. JAMA Neurol. 2015;72:650–5.CrossRefGoogle ScholarPubMed
Lee, SK. Diagnosis and treatment of status epilepticus. J Epilepsy Res. 2020;10:4654.CrossRefGoogle ScholarPubMed
Mahmoud, SH, Marette, V, Lindqvist, T, Ahmed, SN. Critical care management of status epilepticus at a tertiary care university hospital. Can J Neurol Sci. 2019;46:702–10.CrossRefGoogle Scholar
Rodin, E, Krogstad, MH, Aukland, P, et al. High long-term mortality after incident status epilepticus in adults: results from a population-based study. Epilepsia. 2019;60:3341.CrossRefGoogle ScholarPubMed
Kantanen, AM, Sairanen, J, Kälviäinen, R. Incidence of the different stages of status epilepticus in Eastern Finland: a population-based study. Epilepsy and Behavior. 2019;101:106413.CrossRefGoogle ScholarPubMed
Fountain, NB. Status epilepticus: risk factors and complications. Epilepsia. 2000;41:S2330.CrossRefGoogle ScholarPubMed
Ng, MC, Pavlova, M. Status epilepticus in the Canadian arctic: a public health imperative hidden in plain sight. Epilepsia Open. 2021;6:703–13.CrossRefGoogle ScholarPubMed
Bergin, PS, Brockington, A, Jayabal, J, et al. Status epilepticus in Auckland, New Zealand: incidence, etiology, and outcomes. Epilepsia. 2019;60:1552–64.CrossRefGoogle Scholar
DeLorenzo, RJ, Pellock, JM, Towne, AR, Boggs, JG. Epidemiology of status epilepticus. Journal of Clinical Neurophysiology. 1995;12:316–25.CrossRefGoogle ScholarPubMed
Public Health Agency of Canada. Social determinants of health and health inequalities [Internet]. 2023. Available from: https://www.canada.ca/en/public-health/services/health-promotion/population-health/what-determines-health.html. Accessed July 23, 2023.Google Scholar
Canadian Institute for Health Information. Data quality documentation, discharge abstract database- multi-year information. Ottawa, ON: CIHI; 2012.Google Scholar
Canadian Institute for Health Information. National ambulatory care reporting system manual 2009-2010. Ottawa, ON: CIHI; 2009.Google Scholar
Statistics Canada. Census Profile, 2021 Census of Population [Internet]. Ottawa; 2022 Dec. Available from: https://www12.statcan.gc.ca/census-recensement/2021/dp-pd/prof/index.cfm?Lang=E. Accessed January 5, 2023.Google Scholar
Misra, U, Kalita, J. Management of provoked seizure. Ann Indian Acad Neurol. 2011;14:28.CrossRefGoogle ScholarPubMed
Verrotti, A, Scaparrotta, A, Olivieri, C, Chiarelli, F. Seizures and type 1 diabetes mellitus: current state of knowledge. Eur J Endocrinol. 2012;167:749–58.CrossRefGoogle ScholarPubMed
Caramelli, P, Castro, LHM. Dementia associated with epilepsy. Int Psychogeriatr. 2005;17:S195206.CrossRefGoogle ScholarPubMed
Tellez-Zenteno, JF, Patten, SB, Jetté, N, Williams, J, Wiebe, S. Psychiatric comorbidity in epilepsy: a population-based analysis. Epilepsia. 2007;48:2336–44.CrossRefGoogle ScholarPubMed
Gonzalez Castro, LN, Milligan, TA. Seizures in patients with cancer . Cancer. 2020;126:1379–89.CrossRefGoogle ScholarPubMed
Yang, D, Dalton, JE. A unified approach to measuring the effect size between two groups using SAS®. SAS Global Forum. 2012;335:1–6.Google Scholar
Knake, S, Rosenow, F, Vescovi, M, et al. Incidence of status epilepticus in adults in Germany: a prospective, population-based study. Epilepsia. 2001;42:714–8.CrossRefGoogle Scholar
Guidelines for epidemiologic studies on epilepsy. Commission on epidemiology and prognosis, international league against epilepsy. Epilepsia. 1993;34:592–6.CrossRefGoogle Scholar
Tatro, HA, Hamilton, LA, Peters, C, Rowe, AS. Identification of risk factors for refractory status epilepticus. Ann Pharmacother. 2020;54:1421.CrossRefGoogle ScholarPubMed
Bhalla, D, Tchalla, AE, Mignard, C, et al. First-ever population-based study on status epilepticus in French Island of la Reunion (France) - incidence and fatality. Seizure. 2014;23:769–73.CrossRefGoogle Scholar
Tiamkao, S, Pranboon, S, Thepsuthammarat, K, Sawanyawisuth, K. Incidences and outcomes of status epilepticus: a 9-year longitudinal national study. Epilepsy and Behavior. 2015;1:135–7.CrossRefGoogle Scholar
Vignatelli, L, Tonon, C, D’Alessandro, R. Incidence and short-term prognosis of status epilepticus in adults in Bologna, Italy. Epilepsia. 2003;44:964–8.CrossRefGoogle ScholarPubMed
Leitinger, M, Trinka, E, Giovannini, G, et al. Epidemiology of status epilepticus in adults: a population-based study on incidence, causes, and outcomes. Epilepsia. 2019;60:5362.CrossRefGoogle Scholar
Legriel, S, Brophy, GM. Managing status epilepticus in the older adult. J Clin Med. 2016;5:53.CrossRefGoogle ScholarPubMed
Statistics Canada. Sex at birth and gender: technical report on changes for the 2021 Census. Ottawa, ON: Statistics Canada; 2020.Google Scholar
Statistics Canada. Guide to the Census of Population, 2021 Appendix 1.3 - Information produced from the 2021 Census of Population [Internet]. 2021. Available from: https://www.census.gc.ca/census-recensement/2021/ref/98-304/2021001/app-ann1-3-eng.cfm. Accessed July 23, 2023.Google Scholar
Supplementary material: File

Couper et al. supplementary material

Couper et al. supplementary material
Download Couper et al. supplementary material(File)
File 107 KB